logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Anne-Marie C. Dingemans

erasmus mc cancer institute
H指数:71
被引数:2.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Deep molecular profiling of lung neuroendocrine tumours and supra-carcinoids

肺神经内分泌肿瘤和类癌的深层分子谱分析

Molecular Cancer
IF33.9
2026-08-270
OA
Alexandra Sexton-Oates; Émilie Mathian; Noah Candeli; Yuliya Lim; Catherine Voegele; Alex Di Genova; Laurane Mangé; Zhaozhi Li; Tijmen van Weert; Lipika Kalson; Tiffany M. Delhomme; Lisa M. Hillen; Ricardo Blázquez-Encinas; Abel Gonzalez-Perez; Maike L. Morrison; Eleonora Lauricella; Lise Mangiante; Lisa Bonheme; Laura Moonen; Gudrun Absenger; Janine Altmuller; Cyril Degletagne; Odd Terje Brustugun; Vincent Cahais; Giovanni Centonze; Amélie Chabrier; Cyrille Cuenin; Francesca Damiola; Vincent Thomas de Montpréville; Jean-François Deleuze; Anne-Marie C. Dingemans; Élie Fadel; Nicolas Gadot; Akram Ghantous; Paolo Graziano; Paul Hofman; Véronique Hofman; Alejandro Ibáñez-Costa; Stéphanie Lacomme; Nuria Lopez-Bigas; Marius Lund-Iversen; Massimo Milione; Lucia Anna Muscarella; Sergio Pedraza-Arevalo; Corinne Perrin; Gaetane Planchard; Helmut Popper; Luca Roz; Angelo Sparaneo; Wieneke Buikhuisen; José van den Berg; Margot Tesselaar; Jaehee Kim; Ernst Jan M. Speel; Séverine Tabone-Eglinger; Thomas Walter; Gavin M. Wright; Justo P. Castaño; Lara Chalabreysse; Liming Chen; Christophe Caux; Marco Volante; Nicolas Girard; Jean-Michel Vignaud; Esther Conde; Audrey Mansuet-Lupo; Luka Brcic; Giuseppe Pelosi; Mauro Giulio Papotti; Sylvie Lantuejoul; Jules Derks; Talya Dayton; Nicolas Alcala; Matthieu Foll; Lynnette Fernandez-Cuesta
Brief report: Reducing Lorlatinib-related Adverse Events by establishing the Optimal Exposure-Toxicity Threshold in Patients with NSCLC

简报：通过建立最优暴露-毒性阈值来降低NSCLC患者Lorlatinib相关不良反应

Journal of Thoracic Oncology
IF20.8
2026-07-160
OAAI
Daan A.C. Lanser; Lisanne N. van Merendonk; G.D.Marijn Veerman; Salomé van Beusekom; Esther Oomen-de Hoop; Peter de Bruijn; Attila Icli; Marthe S. Paats; Alwin D.R. Huitema; Ron H.N. van Schaik; Sushil Badrising; Anne-Marie C. Dingemans; Ron H.J. Mathijssen
Analysis of SLFN11 expression in small cell lung cancer, carcinoids and large cell neuroendocrine carcinoma: insights into lung neuroendocrine neoplasms

SLFN11在肺小细胞癌、类癌和大细胞神经内分泌癌中的表达分析：对肺神经内分泌肿瘤的见解

Lung Cancer
IF4.4
2026-07-130
OAAI
Daniela Scattolin; Frank W.J. Heijboer; Giulia Pigato; Jules L. Derks; Ernst-Jan M. Speel; Tijmen van Weert; Daphne W. Dumoulin; Biancamaria Di Domenico; Lisa M. Hillen; Valentina Guarneri; Anne-Marie C. Dingemans; Giulia Pasello; Jan H. von der Thüsen
Development of a rapid ex vivo tumor platform for drug response prediction in lung cancer

开发一种用于肺癌药物反应预测的快速离体肿瘤平台

npj Precision Oncology
IF8
2026-07-090
OA
Rianne D. W. Vaes; Zhongli Chen; Iris E. W. G. Laven; Shaowen Lyu; Tessa T. J. Welbers; Jolanda A. F. Piepers; Lisa M. Hillen; Jan H. von der Thüsen; Ruud Clarijs; Didier Decaudin; Elodie Montaudon; Marinus J. Blok; Roy T. M. Sprooten; Lizza E. L. Hendriks; Safiye Dursun; Jos G. Maessen; Juliette H. R. J. Degens; Michiel H. M. Gronenschild; Frank L. J. Custers; Erik R. de Loos; Anne-Marie C. Dingemans; Dik C. van Gent; Marc A. Vooijs; Dirk De Ruysscher
Prospective clinical evaluation of cell-free DNA next generation sequencing in patients with suspected metastatic lung cancer

疑似转移性肺癌患者中游离DNA下一代测序的前瞻性临床评估

Scientific Reports
IF3.9
2026-04-080
OAAI
Christi M. J. Steendam; Ruud W. J. Meijers; Peggy Atmodimedjo; Lisette van Dijk; Cor van der Leest; Keetie C. J. van Loenhout; Susan C. van ’t Westeinde; Daphne W. Dumoulin; Wessel E. J. J. Hanselaar; Marthe S. Paats; Evert de Jonge; Ron H. N. van Schaik; Jan H. von der Thüsen; Joachim G. J. V. Aerts; Anne-Marie C. Dingemans; Hendrikus Jan Dubbink
EORTC 1417 - REACTION: A phase II study of etoposide and cis/carboplatin with or without pembrolizumab in untreated extensive small cell lung cancer

EORTC 1417 - REACTION：一项关于依托泊苷联合顺铂/卡铂，并联合或不联合帕博利珠单抗治疗初治广泛期小细胞肺癌的II期研究

European Journal of Cancer
IF7.1
2025-10-300
PRE
Jessica Menis; Laurent Greiller; Pierre Demontrond; Isabelle Monnet; Silvia Novello; Lorenzo Livi; Robin Young; Chantal Decroisette; Nicolas Cloarec; Gilles Robinet; Roland Schott; Jerome Fayette; Giuseppe Luigi Banna; Filippo De Marinis; Raffaele Califano; Boris Duchemann; Andrea Luciani; Ida Colantonio; Beatrice Fournier; Yassin Pretzenbacher; Caroline Caramella; Mario Silva; Thierry Berghmans; Anne-Marie Dingemans; Paolo Bironzo; Jonathan Tugwood; Cong Zhou; Steven Hill; Kieran Bradbury; Karen Morris; Elaine Kilgour; Caroline Dive; Fiona Blackhall; Benjamin Besse
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity

长期接受帕博利珠单抗单药治疗的患者中，具有晚期非小细胞肺癌、PD-L1表达≥50%且体力状况较差者的长期结局：基于Transformer的AI用于表征预后复杂性

Lung Cancer
IF4.4
2025-10-160
OAAI
Alessio Cortellini; Edoardo Garbo; Giulia La Cava; Fabrizio Citarella; Valentina Santo; Leonardo Brunetti; David J Pinato; Jarushka Naidoo; Monica Loza; Carlo Genova; Scott Gettinger; So Yeon Kim; Ritujith Jayakrishnan; Talal El Zarif; Marco Russano; Federica Pecci; Alessandro Di Federico; Michele Montrone; Dwight H Owen; Diego Signorelli; Mingjia Li; Andrea Camerini; Balazs Halmos; Bruno Vincenzi; Giulio Metro; Sai Yendamuri; Francesco Grossi; Eleni Josephides; Bartłomiej Tomasik; Raffaele Giusti; Emilio Bria; Martin Sebastian; Maximilian Rost; Fabian Acker; Lorenza Landi; Francesca Mazzoni; Alessandro Morabito; Alessandro Leonetti; Luca Cantini; Giannis Mountzios; Sukumar Kalvapudi; David O’Reilly; Eleni Karapanagiotou; Isabelle Monnet; Javier Baena; Marianna Macerelli; Margarita Majem; Aida Piedra; Diego L Cortinovis; Giuseppe Tonini; Gabriele Minuti; Laura Mezquita; Teresa Gorria; Teresa Beninato; Giuseppe Lo Russo; Arsela PrelaJ; Andrea De Giglio; Federica Biello; Frank Aboubakar Nana; Anne-Marie C. Dingemans; Joachim GJV Aerts; Roberto Ferrara; Taher Abu Hejleh; Kazuki Takada; Abdul R Naqash; Marina C Garassino; Heather A. Wakelee; Amin Nassar; Biagio Ricciuti; Paolo Soda; Camillo Maria Caruso; Valerio Guarrasi
Definition of resectable stage III non-small cell lung cancer (NSCLC) for inclusion in clinical trials: A clinical case review by a pan-European multidisciplinary expert panel led by the EORTC Lung Cancer Group

纳入临床试验的可切除III期非小细胞肺癌（NSCLC）定义：由EORTC肺癌组领导的泛欧洲多学科专家小组的临床病例回顾

Lung Cancer
IF4.4
2025-10-140
PRE
Mariana Brandão; Elena Prisciandaro; Eleni Xenophontos; Alessio Mariolo; Amir H. Sadeghi; Andrea R. Filippi; Antonin Levy; Artur Bandura; Caroline Caramella; Chris Dickhoff; Constance de Margerie-Mellon; Corinne Faivre-Finn; Daniel Portik; David Sanchez-Lorente; Dirk De Ruysscher; Egbert Smit; Elisa Gobbini; Elie Fadel; Enrico Ruffini; Emanuela Olmetto; Francesco Cortiula; Idris Bahce; Ilias Houda; Isabelle Opitz; Jarushka Naidoo; John Edwards; Jordi Remon; José Carlos Benitez; Juan Carlos Trujillo; Jules Derks; Karim Amrane; Koen J. Hartemink; Konstantinos Stathopoulos; Lizza E.L. Hendriks; Manoli Iglesias; Mario Occhipinti; Matthias Guckenberger; Niccolo Giaj Levra; Nicolas Girard; Noemi Reguart; Olaf Mercier; Paolo Bironzo; Paul Hofman; René Horsleben Petersen; Riccardo De Angelis; Ronan Abgral; Safae Terrisse; Sanjay Popat; Thomas Pierret; Torsten Gerriet Blum; Umberto Ricardi; Valeria Dionisi; Thierry Berghmans; Anne-Marie C. Dingemans
Determining the optimal approach to identify osimertinib resistance; the first line osimertinib cohort of the OSIRIS study

确定识别奥希康替尼耐药性的最佳方法；OSIRIS研究中的奥希康替尼一线治疗队列

Lung Cancer
IF4.4
2025-09-280
PRE
J.W.T. van der Wel; S.M. Ernst; M. Jebbink; D. van den Broek; S.K. Badrising; L.C. Steinbusch; G. Ruiter; W.S.M.E. Theelen; B.A.M.H. van Veggel; J. Smit; A.M. Dingemans; M.S. Paats; H.J. Dubbink; S.M.S. Hashemi; T. Radonic; D. Cohen; A.J. van der Wekken; A. ter Elst; W. Timens; L.E. Hendriks; E.J.M. Speel; M.M.J. Disselhorst; A. Welling; F. van der Meer; L.J.W. Bosch; K. Monkhorst; M.C. Boelens; E.F. Smit; A.J. de Langen
COMPREHENSIVE ANALYSIS OF NEUROD1, ASCL1, POU2F3 AND YAP1 EXPRESSION SIGNATURES REVEAL UNIQUE LCNEC SUBGROUPS WITH POTENTIAL THERAPEUTIC IMPLICATIONS

对NEUROD1、ASCL1、POU2F3和YAP1表达特征的综合分析揭示了具有潜在治疗意义的独特LCNEC亚群。

Laboratory Investigation
IF4.2
2025-09-010
OAAI
Frank W.J. Heijboer; Jules L. Derks; Dana A.M. Mustafa; Nicole Rijnsburger; Bregtje C.M. Hermans; Lisa M. Hillen; Ernst-Jan M. Speel; Anne-Marie C. Dingemans; Jan H. von der Thüsen
Intracranial activity of sotorasib vs docetaxel in pretreated KRAS G12C-mutated advanced non-small cell lung cancer from a global, phase 3, randomized controlled trial

索托拉西布与多西他赛在经治KRAS G12C突变型晚期非小细胞肺癌中的颅内活性比较：一项全球性、III期、随机对照试验

Lung Cancer
IF4.4
2025-07-290
OAAI
Anne-Marie C. Dingemans; Konstantinos Syrigos; Lorenzo Livi; Astrid Paulus; Sang-We Kim; Yuanbin Chen; Enriqueta Felip; Frank Griesinger; Kadoaki Ohashi; Gerard Zalcman; Brett G.M. Hughes; Jens Benn Sørensen; Normand Blais; Carlos G.M. Ferreira; Colin R. Lindsay; Rafal Dziadziuszko; Patrick J. Ward; Cynthia Chinedu Obiozor; Yang Wang; Solange Peters
Definition of resectable stage III non-small cell lung cancer: A systematic review from EORTC lung cancer group

可切除的III期非小细胞肺癌的定义：一项来自EORTC肺癌组的系统评价

Lung Cancer
IF4.4
2025-07-190
PRE
E. Xenophontos; N. Giaj Levra; V. Durieux; W.H. van Geffen; G. Grisay; C. De la Pinta Alonso; H. Arasanz; E. Prisciandaro; R. Ferrara; J. Derks; J. Von der Thusen; C. Dickhoff; M. Brandão; C. Faivre-Finn; J. Edwards; D.De Ruysscher; J. Remon; A-M.C. Dingemans; T. Berghmans
Deep Learning–Based Retinoblastoma Protein Subtyping of Pulmonary Large-Cell Neuroendocrine Carcinoma on Small Hematoxylin and Eosin–Stained Specimens

基于深度学习的肺大细胞神经内分泌癌小标本苏木精和伊红染色切片Rb蛋白亚型分类

Laboratory Investigation
IF4.2
2025-05-080
OA
Teodora E. Trandafir; Frank W.J. Heijboer; Farhan Akram; Jules L. Derks; Yunlei Li; Lisa M. Hillen; Ernst-Jan M. Speel; Zsolt Megyesfalvi; Balazs Dome; Andrew P. Stubbs; Anne-Marie C. Dingemans; Jan H. von der Thüsen

研究方向

暂未获取到该数据
L
Lizza Hendriks
H 指数:48论文数:432被引数:1.0万
P
Philippe Lambin
H 指数:117论文数:1,889被引数:7.2万
D
Dirk De Ruysscher
H 指数:71论文数:442被引数:1.7万
E
Egbert F. Smit
H 指数:113论文数:1,213被引数:6.0万
R
Ron H.J. Mathijssen
H 指数:76论文数:888被引数:2.0万
G
Gerben Bootsma
H 指数:30论文数:109被引数:3,090
J
Jules L. Derks
H 指数:18论文数:98被引数:1,592
R
Rinus Wanders
H 指数:30论文数:76被引数:3,918
J
Joachim G.J.V. Aerts
H 指数:70论文数:662被引数:3.0万
M
Marthe S. Paats
H 指数:18论文数:78被引数:1,209